SHL Telemedicine (NASDAQ:SHLT) Shares Up 23.7% – Time to Buy?

SHL Telemedicine Ltd. (NASDAQ:SHLT)’s share price traded up 23.7% during mid-day trading on Tuesday . The company traded as high as $3.87 and last traded at $3.50. 108,985 shares were traded during mid-day trading, an increase of 1,123% from the average session volume of 8,910 shares. The stock had previously closed at $2.83.

SHL Telemedicine Stock Performance

The company has a current ratio of 2.17, a quick ratio of 1.98 and a debt-to-equity ratio of 0.19. The company’s fifty day moving average is $2.84 and its 200 day moving average is $3.75.

Institutional Investors Weigh In On SHL Telemedicine

A hedge fund recently bought a new stake in SHL Telemedicine stock. Y.D. More Investments Ltd acquired a new stake in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,219,610 shares of the company’s stock, valued at approximately $11,351,000. SHL Telemedicine comprises about 1.2% of Y.D. More Investments Ltd’s portfolio, making the stock its 22nd largest holding. Y.D. More Investments Ltd owned about 15.12% of SHL Telemedicine as of its most recent SEC filing. Institutional investors and hedge funds own 20.11% of the company’s stock.

SHL Telemedicine Company Profile

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.